← Eichor
Study identifier: NCT04249375 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System

Condition: Adverse Drug Reaction (ADR)  ·  Sponsor: University of British Columbia

PhaseN/A
Planned participants150
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

This project addresses the problem of adverse drug reactions in the three most frequently prescribed therapeutic classes of drugs in children: antibiotics, analgesics, and mental health medications. We will conduct pilot testing of a pharmacogenomic testing panel and study how the tests and generated test results are utilized and understood by physicians, pharmacists, patients and their families.

This description comes directly from the study's public registry record.

Talk to the study team

Bruce Carleton, PharmD.  ·  604-875-2179  ·  bcarleton@popi.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (2)

Children's and Women's Health Centre of British ColumbiaVancouver, British Columbia, CanadaRecruiting
Children's Hospital of Eastern OntarioOttawa, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04249375